"Medicine can have extraordinary meaning. But it cannot substitute for being present in your own life."
In #APieceofMyMind, a psychiatrist and residency program director reflects on an unexpected #LungCancer diagnosis.
ja.ma/48OxHxC
ALT Quote from JAMA, \"I thought I was healthy\u2014a lifelong nonsmoker. A wife and mother of 3. A psychiatrist and residency program director who loves her patients and her residents. And then I was diagnosed with lung cancer.\" - A Piece of My Mind, Jenna Taglienti, MD
Happy to share our paper in @JCardiacFailure 🫀
We found that when using POCUS of the internal jugular veins to estimate RAP in #HeartFailure, the right and left sides of the neck can tell different stories. @MarkDrazner
Here's what we learned 🧵onlinejcf.com/article/S1071-…
Lp(a)-related VTE risk is not uniform & appears hormone-dependent: signal in premenopausal👩🦰and postmenopausal👩🦰on MHT, but not in👨🦰. Sim pub with #ACC.26 @ehj_ed. Congrats @daniel_ezt and 🙏 to co-authors & my co-senior author, mentor & friend @mchonigacademic.oup.com/eurheartj/a…
Now in @ehj_ed#EHJ simutaneous with #ACC26, our analysis of Lp(a) and VTE risk led by ⭐️🇧🇪 @daniel_ezt
Take-🏠: Elevated Lp(a) is associated w/ ⬆️ VTE 🩸 in high-estrogen states (premenopausal 👭, postmenopausal 👭 using hormone therapy)
Paper here: academic.oup.com/eurheartj/a…
Now in @ehj_ed#EHJ simutaneous with #ACC26, our analysis of Lp(a) and VTE risk led by ⭐️🇧🇪 @daniel_ezt
Take-🏠: Elevated Lp(a) is associated w/ ⬆️ VTE 🩸 in high-estrogen states (premenopausal 👭, postmenopausal 👭 using hormone therapy)
Paper here: academic.oup.com/eurheartj/a…
New: @ehj_ed@ESC_Journals in FINE-HEART, 👩🦰 with CKM sx had a ⬆️ burden of multimorbidity but ⬇️ likely to receive indicated CKM therapies than 👨🦰, despite similarly high risks of adverse outcomes. Finerenone had similar benefits. @mvaduganathanacademic.oup.com/eurheartj/a…
APOs and cardiometabolic risk are tightly linked. In our new HCHS/SOL analysis published in @AJPCardio, preconception cardiometabolic abnormalities were associated with higher odds of APOs, with a clear dose response by metabolic syndrome burden. @OdaymeMDsciencedirect.com/science/ar…
Higher aldosterone-renin ratios in older adults were linked to increased risk of atrial fibrillation and ischemic stroke, supporting the aldosterone pathway as a target for cardiovascular disease prevention.
ja.ma/4seQLMK
What an incredible day at the MGB SCAD symposium this past October 🎉
Co-hosted by the MGB Women's Heart Health Program and the SCAD Alliance, we brought together 220 participants from 10 states and 6 countries for a SCAD patient-centered symposium.💙🌎
Thrilled to welcome our new incoming Cardiology Fellows! 🎓❤️
Can’t wait to see the talent, curiosity, and compassion you’ll bring to the program.
Here’s to years of learning, teamwork, and advancing heart care together. #CardioTwitter#MedTwitter
Lots of confusion about menopausal hormone therapy right now —who should get it, when to start, and what is the🫀 risk?
Our new review led by @BrighamMedRes Ruby Guo covers timing, route, and CV risk stratification for midlife women.
🔗: rdcu.be/eSUqJ
🫀 Does sex matter in response to aficamten?
In SEQUOIA-HCM, women with obstructive #HCM were older & had worse baseline status (↑NT-proBNP, ↑LVOT gradients, ↓pVO₂) — yet showed similar improvements in pVO₂, LVOT gradient, and KCCQ as men.
#AHA25@SheilaHegde@wendywangmd